User profiles for H. Ohgaki

Hiroko Ohgaki

Dr
Verified email at charite.de
Cited by 75707

[HTML][HTML] The 2007 WHO classification of tumours of the central nervous system

DN Louis, H Ohgaki, OD Wiestler, WK Cavenee… - Acta …, 2007 - Springer
The fourth edition of the World Health Organization (WHO) classification of tumours of the
central nervous system, published in 2007, lists several new entities, including angiocentric …

[HTML][HTML] The 2016 World Health Organization classification of tumors of the central nervous system: a summary

…, D Figarella-Branger, WK Cavenee, H Ohgaki… - Acta …, 2016 - Springer
… Roughly half of Ep-GBMs express BRAF V600E mutant protein as seen in this example (h) …
FISH revealed MYCN gene amplification limited to the primitive foci of this GBM-PNC (h; …

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

H Ohgaki, P Kleihues - Journal of Neuropathology & …, 2005 - academic.oup.com
Published data on prognostic and predictive factors in patients with gliomas are largely based
on clinical trials and hospital-based studies. This review summarizes data on incidence …

Genetic pathways to primary and secondary glioblastoma

H Ohgaki, P Kleihues - The American journal of pathology, 2007 - Elsevier
Glioblastoma is the most frequent and most malignant human brain tumor. The prognosis
remains very poor, with most patients dying within 1 year after diagnosis. Primary and …

Genetic pathways to glioblastoma: a population-based study

H Ohgaki, P Dessen, B Jourde, S Horstmann… - Cancer research, 2004 - AACR
… Kleihues P, Ohgaki H Phenotype vs genotype in the evolution of astrocytic brain tumors. …
Ohshima H, Bartsch H Chronic infections and inflammatory processes as cancer risk factors: …

Epidemiology and etiology of gliomas

H Ohgaki, P Kleihues - Acta neuropathologica, 2005 - Springer
… histologically confirmed gliomas, 197 meningiomas, 96 acoustic neuromas, and 799
controls), the relative risks associated with cumulative use of cellular phones for more than 100 h

[HTML][HTML] A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization …

…, G Klöppel, WG McCluggage, H Moch, H Ohgaki… - Modern Pathology, 2018 - Elsevier
The classification of neuroendocrine neoplasms (NENs) differs between organ systems and
currently causes considerable confusion. A uniform classification framework for NENs at any …

The definition of primary and secondary glioblastoma

H Ohgaki, P Kleihues - Clinical cancer research, 2013 - AACR
Glioblastoma is the most frequent and malignant brain tumor. The vast majority of
glioblastomas (∼90%) develop rapidly de novo in elderly patients, without clinical or histologic …

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

…, S Nobusawa, P Kleihues, H Ohgaki - The American journal of …, 2009 - Elsevier
IDH1 encodes isocitrate dehydrogenase 1, which participates in the citric acid cycle and was
recently reported to be mutated in 12% of glioblastomas. We assessed IDH1 mutations in …

IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas

S Nobusawa, T Watanabe, P Kleihues, H Ohgaki - Clinical Cancer Research, 2009 - AACR
… gel containing 10% glycerol at 45 W for 2.5 h with cooling by a fan. Gels were dried at 80C
and autoradiographed for 24 to 36 h. Samples with variant bands in SSCP analyses were …